Rankings
▼
Calendar
QURE
uniQure N.V.
$1B
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+11.2% YoY
Gross Profit
-$34M
-1710.8% margin
Operating Income
-$45M
-2262.4% margin
Net Income
-$37M
-1836.7% margin
EPS (Diluted)
$-0.79
QoQ Revenue Growth
-99.6%
Cash Flow
Operating Cash Flow
-$40M
Free Cash Flow
-$48M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$775M
Total Liabilities
$184M
Stockholders' Equity
$591M
Cash & Equivalents
$578M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
+11.2%
Gross Profit
-$34M
$2M
-2002.0%
Operating Income
-$45M
-$44M
-1.1%
Net Income
-$37M
-$54M
+32.1%
Revenue Segments
Collaborative Revenue
$2M
100%
← FY 2021
All Quarters
Q4 2021 →
QURE Q3 2021 Earnings — uniQure N.V. Revenue & Financial Results | Market Cap Arena